Paclitaxel in doxorubicin-resistant metastatic breast cancer patients
- PMID: 7563210
- DOI: 10.1093/jnci/87.21.1642
Paclitaxel in doxorubicin-resistant metastatic breast cancer patients
Comment on
-
Paclitaxel in metastatic breast cancer: a trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines.J Natl Cancer Inst. 1995 Aug 2;87(15):1169-75. doi: 10.1093/jnci/87.15.1169. J Natl Cancer Inst. 1995. PMID: 7674322 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
